Cape Verde vs Mozambique: Previously treated cases tested for RR-/MDR-TB
Cape Verde
20.0%
in 2024
Mozambique
25.0%
in 2024
Cape Verde rank
165th
Mozambique rank
164th
Previously treated cases tested for RR-/MDR-TB over time
- Cape Verde
- Mozambique
How they compare
Mozambique currently reports 25.0% against 20.0% in Cape Verde, a difference of 5.0%.
That makes Mozambique's figure about 1.2 times Cape Verde's.
The two have swapped places 6 times across 15 shared years of data; in 2008 it was Mozambique ahead.
Cape Verde ranks 165th and Mozambique ranks 164th of 180 countries.
Mozambique has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Cape Verde | Mozambique | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.6% | 10.9% | 9.3% | Mozambique |
| 2010s | 19.5% | 35.3% | 15.8% | Mozambique |
| 2020s | 59.6% | 72.4% | 12.8% | Mozambique |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Cape Verde or Mozambique?
- Mozambique, at 25.0% against 20.0% in Cape Verde as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Cape Verde and Mozambique?
- 5.0%, with Mozambique ahead.
- How many years of comparable data are there for Cape Verde and Mozambique?
- 15 years are reported by both, from 2008 to 2024.
- How do Cape Verde and Mozambique rank globally for previously treated cases tested for rr-/mdr-tb?
- Cape Verde ranks 165th and Mozambique ranks 164th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.